NO980718D0 - Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer - Google Patents

Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer

Info

Publication number
NO980718D0
NO980718D0 NO980718A NO980718A NO980718D0 NO 980718 D0 NO980718 D0 NO 980718D0 NO 980718 A NO980718 A NO 980718A NO 980718 A NO980718 A NO 980718A NO 980718 D0 NO980718 D0 NO 980718D0
Authority
NO
Norway
Prior art keywords
bicyclic
tyrosine kinase
kinase inhibitors
aralkylaminopyrimidine
derivatives
Prior art date
Application number
NO980718A
Other languages
English (en)
Other versions
NO980718L (no
Inventor
Maria Gabriella Brasca
Dario Ballinari
Antonio Longo
Franco Buzzetti
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO980718D0 publication Critical patent/NO980718D0/no
Publication of NO980718L publication Critical patent/NO980718L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
NO980718A 1996-06-21 1998-02-20 Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer NO980718L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613021.6A GB9613021D0 (en) 1996-06-21 1996-06-21 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
PCT/EP1997/002965 WO1997049689A1 (en) 1996-06-21 1997-06-03 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors

Publications (2)

Publication Number Publication Date
NO980718D0 true NO980718D0 (no) 1998-02-20
NO980718L NO980718L (no) 1998-04-08

Family

ID=10795666

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980718A NO980718L (no) 1996-06-21 1998-02-20 Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer

Country Status (20)

Country Link
US (1) US6057326A (no)
EP (1) EP0853616B1 (no)
JP (1) JPH11511761A (no)
KR (1) KR19990043993A (no)
CN (1) CN1198158A (no)
AR (1) AR008614A1 (no)
AT (1) ATE205836T1 (no)
AU (1) AU3094197A (no)
BR (1) BR9702328A (no)
CA (1) CA2228492C (no)
DE (1) DE69706823T2 (no)
EA (1) EA199800215A1 (no)
ES (1) ES2165061T3 (no)
GB (1) GB9613021D0 (no)
HU (1) HUP9902026A3 (no)
IL (1) IL123124A0 (no)
NO (1) NO980718L (no)
PL (1) PL325122A1 (no)
WO (1) WO1997049689A1 (no)
ZA (1) ZA975380B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6347480B1 (en) * 1997-07-07 2002-02-19 Southpac Trust International, Inc. Method for wrapping a floral grouping with a sheet of material constructed of paper and having printed and embossed patterns thereon
IL125686A (en) 1996-02-13 2002-11-10 Zeneca Ltd Quinazoline derivatives, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of a drug with an anti-angiogenic effect and / or an effect of reducing vascular permeability
DE69709319T2 (de) 1996-03-05 2002-08-14 Astrazeneca Ab 4-anilinochinazolin derivate
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
US6608060B1 (en) 1996-12-18 2003-08-19 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US5945418A (en) * 1996-12-18 1999-08-31 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US6147080A (en) * 1996-12-18 2000-11-14 Vertex Pharmaceuticals Incorporated Inhibitors of p38
DE19653646A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
EP1230225A2 (en) * 1999-11-01 2002-08-14 Eli Lilly And Company Pharmaceutically active 4-substituted pyrimidine derivatives
US7173038B1 (en) 1999-11-05 2007-02-06 Astrazeneca Ab Quinazoline derivatives as VEGF inhibitors
WO2003009852A1 (en) * 2001-07-24 2003-02-06 Merck & Co., Inc. Tyrosine kinase inhibitors
KR100468352B1 (ko) * 2002-09-24 2005-01-27 한국과학기술연구원 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물
BRPI0413563A (pt) * 2003-08-15 2006-10-17 Irm Llc compostos e composições como inibidores de atividade do receptor de quìnase de tirosina
MXPA06009475A (es) * 2004-02-19 2007-05-15 Rexahn Corp Derivados de quinazolina y usos terapeuticos de los mismos.
US7151176B2 (en) * 2004-10-21 2006-12-19 Bristol-Myers Squibb Company Pyrrolotriazine compounds
ES2319462T3 (es) * 2005-03-28 2009-05-07 Bristol-Myers Squibb Company Inhibidores competitivos de atp cinasas.
TWI385174B (zh) * 2008-11-10 2013-02-11 Nat Health Research Institutes 作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物
UA110113C2 (xx) * 2010-07-29 2015-11-25 Біциклічні азагетероциклічні карбоксаміди
EP2655374B1 (en) * 2010-12-20 2019-10-23 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89028A0 (en) * 1988-01-29 1989-08-15 Lilly Co Eli Quinoline,quinazoline and cinnoline derivatives
ZA902280B (en) * 1989-03-29 1990-12-28 Merrell Dow Pharma Selective adenosine receptor agents
JP2762430B2 (ja) * 1991-01-18 1998-06-04 宇部興産株式会社 アラルキルアミノピリミジン類の製法
US5710158A (en) * 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
JPH06172321A (ja) * 1992-10-08 1994-06-21 Agro Kanesho Co Ltd 置換アミノピリミジン誘導体、その製造法及びそれを有効成分とする有害生物駆除剤
GB9313638D0 (en) * 1993-07-01 1993-08-18 Erba Carlo Spa Arylidene and heteroarylidene oxindole derivatives and process for their preparation
GB9326136D0 (en) * 1993-12-22 1994-02-23 Erba Carlo Spa Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
GB9406137D0 (en) * 1994-03-28 1994-05-18 Erba Carlo Spa N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
GB9412719D0 (en) * 1994-06-24 1994-08-17 Erba Carlo Spa Substituted azaindolylidene compounds and process for their preparation
GB9423997D0 (en) * 1994-11-28 1995-01-11 Erba Carlo Spa Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation

Also Published As

Publication number Publication date
KR19990043993A (ko) 1999-06-25
EA199800215A1 (ru) 1998-08-27
CA2228492C (en) 2007-05-08
DE69706823T2 (de) 2002-04-11
EP0853616A1 (en) 1998-07-22
HUP9902026A2 (hu) 2000-04-28
ES2165061T3 (es) 2002-03-01
MX9801408A (es) 1998-05-31
WO1997049689A1 (en) 1997-12-31
CN1198158A (zh) 1998-11-04
DE69706823D1 (en) 2001-10-25
AU3094197A (en) 1998-01-14
US6057326A (en) 2000-05-02
GB9613021D0 (en) 1996-08-28
BR9702328A (pt) 1999-07-20
AR008614A1 (es) 2000-02-09
ATE205836T1 (de) 2001-10-15
IL123124A0 (en) 1998-09-24
HUP9902026A3 (en) 2000-07-28
NO980718L (no) 1998-04-08
PL325122A1 (en) 1998-07-06
CA2228492A1 (en) 1997-12-31
JPH11511761A (ja) 1999-10-12
ZA975380B (en) 1998-01-05
EP0853616B1 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
DK1000039T3 (da) Substituerede quinazolinderivater og anvendelse deraf som tyrosinkinaseinhibitorer
NO980718D0 (no) Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer
DK0915880T3 (da) Azolotriaziner og pyrimidiner
NO992336D0 (no) Raf-kinase-inhibitorer
NO20002121D0 (no) Benzotiazol-protein-tyrosin-kinaseinhibitorer
AU2396897A (en) 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
NO974453D0 (no) Proteinkinase C-hemmere
DE69600784D1 (de) Proteinkinase-C-Inhibitor
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
DE69435267D1 (de) Proteinkinase C Inhibitoren
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
DK1015444T3 (da) Pyrimidinderivater og fremgangsmåder til fremstilling deraf
DK0906301T3 (da) Benzofurylderivater og anvendelsen deraf
PT927183E (pt) Inibidores espirociclicos de metaloproteases
PT956294E (pt) Inibidores da trombina
AU3885900A (en) Inhibitors of the egf-receptor tyrosine kinase and their use
PT934280E (pt) Derivados 2-cianoiminoimidazolo inibidores da pde iv
NO986174L (no) Triazinderivater og anvendelse derav
DK0906268T3 (da) Alkoxyaminosubstituerede fluorenoner og deres anvendelse som proteinkinase C-inhibitorer
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
GB0102712D0 (en) Cytokine Producion and Tyrosine Kinase Inhibitors
SI0906268T1 (en) Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
GB9600997D0 (en) N-indolinyl-pyridopyrimidines as tyrosine kinase inhibitors
GB9425409D0 (en) Inhibitors of protein tyrosine kinases